A comprehensive view of Licensing / Royalty. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Samsung Bioepis settles patent litigation with J&J, paving way for US sales of plaque psoriasis treatment SB17 from February 22, 2025, upon FDA approval; Sandoz to handle commercialization
Published: December 01, 2023 by PharmaShots
Elevai Labs enters licensing agreement with Yuva Biosciences to potentially develop topical skin-care formulations that combine mitochondrial biology with Elevai’s human umbilical mesenchymal stem cell derived exosomes
Published: November 29, 2023 by GlobeNewswire
AstraZeneca enters into US$419.0M licensing agreement with Yousen Jianheng for the development and commercialization of cancer drug UA022; the early-stage small molecule drug candidate targets KRASG12D mutation
Published: November 22, 2023 by Marketline - Deals
HeartSciences announces closing of license agreements with the Icahn School of Medicine at Mount Sinai to develop and commercialize AI cardiovascular algorithms
Published: November 20, 2023 by GlobeNewswire
Indian Oil to license LyondellBasell’s Hostalen ‘Advanced Cascade Process’ technology for a new 200 kiloton/year HDPE plant that will be built in Panipat, India; plant will commence operations using Avant Z501 and Avant Z509-1 catalysts
Published: November 17, 2023 by LyondellBasell Industries NV

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count